Acute Respiratory Distress Network (ARDSNet) Studies 07, 08, 09, 11, and 12 Early Versus Delayed Enteral Feeding to Treat People with Acute Lung Injury or Acute Respiratory Distress Syndrome (EDEN) - Catalog

  • Name

    Acute Respiratory Distress Network (ARDSNet) Studies 07, 08, 09, 11, and 12 Early Versus Delayed Enteral Feeding to Treat People with Acute Lung Injury or Acute Respiratory Distress Syndrome (EDEN)

  • Accession Number

    HLB01171414a

  • Acronym

    ARDSNet-EDEN

  • Related studies
  • BSI Study IDs

    AR9

    AR11

    AR7 (Not Included in Utilization Report)

    AR8 (Not Included in Utilization Report)

    AR12 (Not Included in Utilization Report)

  • Is public use dataset

    False

  • Keywords
  • Ingestion Status
    Released
  • Has Study Datasets

    True

  • Has Specimens

    True

  • Specimen ID Type
    Coded
  • Study Website

    http://www.ardsnet.org/

  • The Framingham Heart Study Group requires that the requestor must obtain full or expedited IRB/Ethics Committee review and approval to obtain these data. Waivers or a determination that the research is exempt from ethical regulations do not suffice.

    False

  • Clinical Trial URLs
  • Study type
    Clinical Trial
  • Collection Type
    Open BioLINCC Study
  • Cohort type
    Adult
  • Interventions

    Behavioral: Minimal (Trophic) FeedingBehavioral: Full Feeding

  • Study Open Date (Data)

    2014-10-07

  • Study Open Date (Specimens)

    2014-10-07

  • Date materials available

    2014-10-02

  • Last updated

    2014-10-02

  • Study period

    12/2007 – 5/2011

  • Study Contacts
  • NHLBI Division

    DLD

  • Classification
    Lung
  • HIV study classification
    non-HIV
  • COVID study classification
    non-COVID
  • Pre-Website # of Specimens Shipped

    0

  • # of Returned Specimens

    0

  • Primary Publication URLs
  • Conditions
    ALI
    ARDS
    Acute Lung Injury
    Lung Diseases
    Respiratory Distress Syndrome, Adult
  • Objectives

    To determine if initial lower-volume trophic enteral feeding would increase ventilator-free days (VFDs) and decrease gastrointestinal intolerances compared with initial full enteral feeding.

  • Background

    Mechanically ventilated patients cannot eat normally and if not fed for long periods become malnourished. Because malnutrition is associated with poor outcomes in critically ill patients, artificial nutrition is often provided, especially in those with acute lung injury (ALI) and with expected longer duration of mechanical ventilation. When feasible, enteral nutrition targeting full caloric needs has been advocated over parenteral nutrition. However, feeding intolerance and common care practices often serve as practical barriers to reaching recommended goals.


    Although confounded by indication and severity of illness, several observational studies have shown improved clinical outcomes, including fewer infections, shorter duration of mechanical ventilation, and lower mortality for patients receiving a higher percentage of calculated caloric needs. Nonetheless, the best timing, formulation, and amount of enteral nutrition remain unknown.

  • Participants

    Patients within 48 hours of ALI onset who had received mechanical ventilation for less than 72 hours and whose physicians intended to administer enteral nutrition were eligible. ALI was defined by a ratio of the partial pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen (FIO2) of less than 300 (adjusted if altitude exceeded 1000 m) with bilateral pulmonary infiltrates consistent with edema on chest radiograph without clinical evidence of left atrial hypertension.

  • Design

    Participants were randomized, stratified by site and presence of shock at enrollment, to receive either trophic or full enteral feeding for the first 6 days of mechanical ventilation. The initial 272 patients were also simultaneously randomized to a separate trial (the OMEGA study) comparing a nutritional supplement containing omega-3 fatty acids and antioxidants with an isocaloric, isovolemic control in a 2 × 2 factorial design.


    The designated feeding strategy was initiated within 6 hours of randomization and continued until death, extubation, or day 6. The care of mechanically ventilated patients still receiving enteral feedings after day 6 was managed according to the full feeding strategy in both groups. In extubated patients who then required reintubation, enteral nutrition was restarted and managed according to the study protocol.


    In the full-feeding group, enteral nutrition was initiated at 25 mL/h and advanced to goal rates as quickly as possible. Gastric residual volumes were checked every 6 hours while enteral feeding was increased. Patients randomized to the initial trophic-feeding group had enteral nutrition initiated at 10 mL/h (10-20 kcal/h) for the first 272 patients who also received the omega-3 or control supplement (240 mL volume per day). After the data and safety monitoring board stopped the OMEGA portion of the factorial design, the initial trophic feeding rate was changed to 20 kcal/h to approximate the calories that had been delivered in the OMEGA study. GRVs were checked every 12 hours during trophic feeding. In patients randomized to trophic feeding, enteral nutrition was advanced to full-energy feeding rates following the same protocol used for the full-feeding group if they were still receiving mechanical ventilation at 144 hours.

  • Conclusions

    There was no difference between groups with regard to the primary end point, VFDs to day 28. There also were no differences in 60-day mortality, organ failure−free days, ICU-free days, or the incidence of infection between groups. Similarly, there were no differences between groups in VFDs or survival when analyzed by body mass index category or when subsets of patients with shock or more severe lung injury (acute respiratory distress syndrome) were examined.


    JAMA. 2012 Feb 22;307(8):795-803.

  • Disease classification
  • Publications
  • Mat types
    Bronchial Lavage
    DNA
    Plasma
    Urine
  • Network
    Acute Respiratory Distress Network (ARDSNet)

The study population available in BioLINCC study data may be lower than total study enrollment due to Informed Consent restrictions and other factors.

  • Subjects

    Trophic Feeding: 508

    Full Feeding: 492


    Last Modified: April 5, 2024, 3:59 p.m.
  • Age
     EDEN fullEDEN trophicAll
    N%N%N%
    17-2081.63122.36202.00
    21-25183.66203.94383.80
    26-30204.07356.89555.50
    31-35255.08265.12515.10
    36-40367.32326.30686.80
    41-45418.33479.25888.80
    46-507515.245110.0412612.60
    51-558016.266813.3914814.80
    56-605110.376212.2011311.30
    61-65408.13448.66848.40
    65-70387.72377.28757.50
    71-75193.86254.92444.40
    76-80173.46305.91474.70
    81-85163.25122.36282.80
    86-8981.6371.38151.50

    Last Modified: April 5, 2024, 3:59 p.m.
  • Sex
     EDEN fullEDEN trophicAll
    N%N%N%
    Female24950.6124147.4449049.00
    Male24349.3926752.5651051.00

    Last Modified: April 5, 2024, 3:59 p.m.
  • Race
     EDEN fullEDEN trophicAll
    N%N%N%
    Not reported183.66275.31454.50
    White37576.2238776.1876276.20
    African American8016.267915.5515915.90
    Other193.86152.95343.40
     EDEN fullEDEN trophicAll
    N%N%N%
    Hispanic or Latino5811.796011.8111811.80
    Not Hispanic or Latino43488.2144888.1988288.20

    Last Modified: April 5, 2024, 3:59 p.m.

Please note that biospecimen availability is subject to review by the NHLBI, BioLINCC, and the NHLBI Biorepository. Certain biospecimens may not be made available for your request. Section 3.0 of the BioLINCC Handbook describes the components of the review process.

  • Material Types

    Plasma, DNA, Urine, BAL


    Last Modified: April 5, 2024, 3:59 p.m.
  • General Freeze/Thaw Status
  • Visits (Vials)

    04/05/2024

     

    Plasma

    DNA

    Urine

    Bronchial Lavage

    Total

    Day 0

    4,758

    892

    2,981

    12

    8,643

    Day 3

    3,756

    0

    3,153

    1

    6,910

    Day 6

    2,314

    0

    2,014

    0

    4,328

    Day 12

    1,228

    0

    16

    0

    1,244


    Last Modified: April 5, 2024, 3:59 p.m.
  • Visits (Subjects)

    04/05/2024

     

    Plasma

    Total number of subjects

    Average volume (ml) per subject

    Day 0

    990

    2.46

    Day 3

    853

    3.97

    Day 6

    605

    5.14

    Day 12

    277

    6.03

     

     

    DNA

    Total number of subjects

    Average mass (µg) per subject

    Average volume (ml) per subject

    Day 0

    878

    677.04

    0.99

     

     

    Urine

    Total number of subjects

    Average volume (ml) per subject

    Day 0

    941

    5.17

    Day 3

    804

    6.44

    Day 6

    548

    5.53

    Day 12

    4

    6.65

     

     

    Bronchial Lavage

    Total number of subjects

    Average volume (ml) per subject

    Day 0

    4

    0.85

    Day 3

    1

    0.15


    Last Modified: April 5, 2024, 3:59 p.m.